Converus Stock
Converus provides scientifically validated credibility assessment technologies.
Sign up today and learn more about Converus Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Converus Stock
Converus provides scientifically validated credibility assessment technologies that help protect countries, corporations, and communities from corruption, crime, and threats. Today, Converus offers 3 main products. It has developed a technology called EyeDetect that detects deception by scanning the human eye in a non-invasive manner. Converus also offers a product called IdentityDetect, a quick and simple web-based test or mobile app that can quickly verify a person’s identity. While it IntegrityDetect is a unique integrity-assessment test designed to replace the traditional integrity test.
Funding History
March 2013 | $1.3M |
---|---|
November 2014 | $1.4M |
January 2017 | $3.9M |
Management
VP Marketing and Operations
Russ Warner
President & CEO
Todd Mickelsen
Chief Technology Officer
Ben Stout
Chief Software Architect
Greg Parkinson
Vice President, Corporate Communications
Jeff Pizzino
Press
philstar - Dec, 20 2023
Doping a big no-no, says Obienahealthtree - Dec, 20 2023
Launch of HealthTree 2.0 - HealthTree for Multiple Myelomanews - Dec, 20 2023
Are Polygraphs Really the Best Method? - ClearanceJobsdeepai - Aug, 20 2020
ConvGRU in Fine-grained Pitching Action Recognition for Action Outcome Predictionprnewswire - Jun, 6 2019
EyeDetect Can Now Accurately Score 4 Target Issues in One Lie Detector Test